Use of Short-Course Radiation Therapy for Lymphomas | JAMA Health Forum

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, JULY 1, 2022

Media advisory: The full study is linked to this news release.

Free access to the full-text article: https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.1815?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=070122

Click here to register … | Learn More About Workshops and More. Photo Credit/Source: (C) Concierge Medicine Today, LLC/The DocPreneur Leadership Podcast/Academy

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

About The Study: This analysis evaluated changes in the use of and spending on short-course radiation therapy among Medicare beneficiaries with low-grade lymphoma from 2015 to 2019 with Centers for Medicare & Medicaid Services payment data.

Authors: Brandon S. Imber, M.D., M.A., of Memorial Sloan Kettering Cancer Center in New York, is the corresponding author.

(doi:10.1001/jamahealthforum.2022.1815)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

SOURCE: https://media.jamanetwork.com/news-item/use-of-short-course-radiation-therapy-for-lymphomas/

Next Post

Cancer Clinical Trials Bounce Back After Significant COVID-19 Disruption: Data From Two Large US Cancer Centres [Annals of Oncology Press Release]

Fri Jul 8 , 2022
ESMO Newsroom Press Releases […]

Breaking News